key: cord-1002971-gdzdeiwf authors: Visveswaran, Gautam K.; Morparia, Kavita; Narang, Shalu; Sturt, Cindy; Divita, Michael; Voigt, Brett; Hawatmeh, Amer; McQueen, Derrick; Cohen, Marc title: SARS-CoV-2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child date: 2020-07-13 journal: J Pediatr DOI: 10.1016/j.jpeds.2020.07.032 sha: 1f580b0d64c20511eef421e60b7167044df15163 doc_id: 1002971 cord_uid: gdzdeiwf A 12-year-old female with SARS-CoV-2 infection presented as phlegmasia cerulea dolens with venous gangrene.. Emergent mechanical thrombectomy was complicated by a massive pulmonary embolism and cardiac arrest for which extracorporeal cardiopulmonary resuscitation and therapeutic hypothermia were employed. Staged-ultrasound assisted catheter directed thrombolysis was employed for treatment of bilateral pulmonary emboli and the extensive lower extremity deep vein thrombosis while the patient received extracorporeal membrane oxygenation support. We highlight the need for heightened suspicion for occult SARS-CoV-2 infection among children presenting with unusual thrombotic complications. 2 support. We highlight the need for heightened suspicion for occult SARS-CoV-2 infection among children presenting with unusual thrombotic complications. Phlegmasia cerulea dolens (PCD) characterized by extensive venous thrombosis and severe venous outflow obstruction presents with painful limb swelling, cyanosis, and gangrene in extreme cases. Occurrence of PCD in healthy pediatric patients is rare [1] [2] [3] . Potential protective mechanisms cited include a reduced capacity for thrombin generation, increased alpha-2 macroglobulin inhibition of thrombin, and the antithrombotic potential of the vessel wall 2 . Among adult and pediatric patients, malignancy, sepsis, surgery, hypercoagulable state, and vascular injury (indwelling central lines) predispose to PCD [2] [3] [4] . Coronavirus disease associated with the 2019 novel coronavirus (SARS-Cov-2) is associated with a hypercoagulable state among adults 5, 6 , as is the multisystem inflammatory syndrome in 3 children (MIS-C) 7, 8 . We report the case of a girl with PCD and venous gangrene in association with SARS-CoV-2 infection. A 12-year-old previously healthy girl (BMI 20.1 kg/m 2 ) had the acute onset of painful swelling of her left leg without dyspnea or fever. She was evaluated 5 days prior for painful erythema of the left thigh of 5 days duration, diagnosed as cellulitis and treated with oral trimethoprim-sulfamethoxazole. No intercurrent illness, sick contacts, long distance travel, familial thrombophilia, or trauma were reported. Vital signs on admission: BP 135/76 mmHg, HR 140 b/min (sinus tachycardia), RR 20 breaths/min, Temp 98.2°F. Examination revealed marked swelling of the entire left leg that was cool to touch. Her left foot was ecchymotic with decreased sensation and inability to flex toes, but dorsalis pedis and posterior tibial pulses were palpable ( Figure 1 ). Laboratory tests before unfractionated heparin (UFH) administration showed thrombocytopenia (126,000/µL), prolonged PT 18 secs (normal high 13.4 secs), PTT 88.3 secs (normal high 36.6 secs), elevated D-dimer 1953 ng/mL (high normal ≤243ng/mL) and factor VIII activity 259.4% (normal range 62% -194%). ESR was >130 mm/hr (normal high 13 mm/hr) and CRP was 14.8 mg/dL (normal high 0.5 mg/dL). Because catheter-directed lysis requires hours for revascularization, we proceeded to percutaneous mechanical venous thrombectomy. Venography confirmed extensive popliteal-tocommon iliac vein thrombosis and excluded inferior vena cava clot (Video 1 and Video 2; available at www.jpeds.com). ClotTriever mechanical thrombectomy (Inari Medical) retrieved white and red fibrin rich clot. Thrombectomy was complicated by hypotension, bradycardia, and pulseless electrical activity (PEA) for which cardiopulmonary resuscitation was initiated. Echocardiogram revealed severe right ventricular (RV) dilation with severe hypokinesis 4 consistent with acute massive pulmonary embolism (PE). A multidisciplinary decision was made to initiate peripheral veno-arterial (VA) extracorporeal membrane oxygenation (ECMO). Table] . Paralytics and sedation were weaned on day 4 and she awoke, followed commands, and was successfully extubated to oxygen via nasal cannula. Complete normalization of her RV function was noted on Day 7 echocardiogram (Video 3; available at www.jpeds.com). The patient was given solumedrol 1 g (23 mg/kg) daily for 3 doses, followed by a taper. Plasmapheresis was undertaken daily for 5 days, and three times afterwards for a total of 8 treatments. Empiric antibiotics with vancomycin and cefepime were administered for 5 days. COVID-19 respiratory syndrome is associated with a hypercoagulable state in adults 5, 6 . Severe hypoxia, systemic inflammation/sepsis/cytokine surge and an "endothelitis" prompting prothrombotic states have been postulated mechanisms 12, 13 . An elevated D-dimer, low normal or normal fibrinogen level, elevated fibrin degradation products, mild thrombocytopenia and mildly elevated PTT in adults with severe COVID-19 has led some to postulate the occurrence of a compensated DIC syndrome 14, 15 . Non-survivors met ISTH criteria for DIC in 71.4 % of patients vs 0.6% among COVID-19 survivors in one ICU study 15 . Admission coagulation tests were markedly abnormal in our patient. She met ISTH criteria for non-overt DIC; ISTH DIC score 4: prolonged PT (1 point) and severely elevated D -dimer (3 points) 16 . Importantly, her investigation for acute infection was negative. Thrombophilia work up was positive for antiphospholipid antibodies. Pediatric primary APS (antiphospholipid syndrome) is rare, and disease onset before age 15 is reported in only 2.8% of all pediatric APS. Although arterial thrombosis is more often associated with primary APS, DVT is predominantly seen with secondary APS 17 . Adult COVID-19 associated APLA and LA have been reported 18, 19 . With repeat confirmatory APS testing pending, given the rarity of pediatric PCD, admission DIC score of 4 with positive APLA and anti-SARS-CoV-2 IgM assay, we opine that the PCD likely was the result of a community-acquired SARS-CoV-2 induced hypercoagulable state. Phlegmasia in an adult COVID-19 patient managed with UFH has recently been reported 20 . SARS-CoV-2 infection is now known to cause pediatric multisystem inflammatory syndromechildren (MIS-C) with significant associated morbidity and mortality. 21, 22, 23 . Chilblain-like lesions labeled "COVID toes", are the predominant dermatologic manifestation reported among otherwise healthy older children with a strong epidemiologic association with COVID-19 24 . Predominantly involving bilateral toes and feet, "COVID toes" are characterized by 7 erythematous macules/papules, purpuric lesions with pruritis and mild pain with rare acroischemia reported 24, 25 . Reports indicate that most patients test negative on nasopharyngeal RT-PCR tests and for IgG and IgM antibodies to SARS-CoV-2 24 . Coagulation studies and lupus anticoagulant tests usually are normal 26 . Vascular microthrombus formation is suspected. Spontaneous resolution without significant sequelae is common 24, 26 . Our patient presented with venous gangrene and an acutely threatened limb. Emergent mechanical thrombectomy was complicated by a massive PE and cardiac arrest. Absence of IVC clot, her adolescent age, known complications of IVC filters, and the purported design advantages of the ClotTriever® with a coring element and a nitinol collection bag for distal protection 27,28 biased our decision not to insert a prophylactic IVC filter. In retrospect, filter placement likely would have captured dislodged emboli 29 and prevented cardiac arrest. Systemic thrombolysis was considered but given the nonperfusing rhythm and add on time (TPA bolus over ~15 mins plus time for TPA action) institution of VA ECMO was clinically warranted. Improved survival (40% vs. 27%) and survival with favorable neurologic outcome (27% vs 18%) have been reported with use of ECPR vs conventional CPR in pediatric in-hospital cardiac arrest 30 . CNS events (ischemic stroke, ICH and brain death) and bleeding negatively impact ECPR outcomes 31, 32 . Therapeutic hypothermia likely contributed to her complete neurologic recovery. A staged EkoSonic TM UCDT for bilateral PE facilitated early ECMO decannulation 33 . UCDT has been shown to decrease the burden of pulmonary embolus, decrease pulmonary pressures and facilitate early RV recovery 9, 34 . Rheolytic thrombectomy plus UDCT significantly improved venous outflow and prevented major amputation. Systemic or catheter directed thrombolysis also has been shown to decrease the risk of post-thrombotic syndrome in children 35 . Adjunctive corticosteroid therapy and plasmapheresis was undertaken upon the finding of 8 APLA. Plasmapheresis likely confounded SARS-CoV-2 antibody testing. Repeated serology confirmed our suspicion of relationship to SARS-CoV-2 infection. SARS-CoV-2 infection should be considered in the differential diagnosis for children with unusual thrombotic presentations. Earlier detection and treatment of coagulopathy may prevent severe complications of the nature described here. We thank the dedicated nursing staff of the pediatric intensive care unit, surgical, and catheterization laboratory for the exceptional care delivered. A multimodal therapeutic approach to phlegmasia cerulea dolens in a pediatric patient Pediatric venous thromboembolism in relation to adults Phlegmasia Cerulea Dolens in the Pediatric Population: A Lifethreatening Condition Venous gangrene of lower extremities and Staphylococcus Aureus sepsis Incidence of venous thromboembolism in hospitalized patients with COVID-19 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Characteristics, Cardiac involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: An alternative in patients with contraindications to thrombolysis Interpreting Diagnostic Tests for SARS-CoV-2 COVID-19 and coagulative axis: review of emerging aspects in a novel disease Endothelial cell infection and endotheliitis in COVID-19 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: A systematic review and meta-analysis or r e sp ondence Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 COVID-19 infection with extensive thrombosis: A case of phlegmasia cerulea dolens Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units Hyperinflammatory shock in children during COVID-19 pandemic Acute heart failure in multisystem inflammatory syndrome in children ( MIS-C ) in the context of global SARS-CoV-2 pandemic A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection Acute Acro-Ischemia in the Child At the Time of Covid-19 Chilblains in children in the setting of COVID-19 pandemic Effective single-session percutaneous nonpharmacologic mechanical thrombectomy for phlegmasia cerulea dolens Technical success and short-term outcomes after treatment of lower extremity deep vein thrombosis with the ClotTriever system: A preliminary experience Efficacy of Retrievable Inferior Vena Cava Filter Placement in the Prevention of Pulmonary Embolism during Catheter-Directed Thrombectomy for Proximal Lower-Extremity Deep Vein Thrombosis Extracorporeal-Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest is Associated with Improved Survival to Discharge: A Report from the American Heart Association's Get With the Guidelines®-Resuscitation Registry (GWT Pediatric Extracorporeal Life Support Organization Registry International Report Characteristics, risk factors & outcomes of extracorporeal membrane oxygenation use in pediatric cardiac intensive care units: a report from the PC4 Registry Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patients Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study Athrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children Legends Figure 1. Severely swollen, painful, cyanotic left lower extremity on presentation Lupus Anticoagulant: DRVVT; LAC Ratio 79.6 seconds IgM <9